Zenas BioPharma, Inc. Payments to Acquire in Process Research and Development
Zenas BioPharma, Inc. (ZBIO) reported Payments to Acquire in Process Research and Development of $30.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2026-08-13
- 2026-06-30: Payments to Acquire in Process Research and Development 6 month $30.00M.
| Period end | Payments to Acquire in Process Research and Development 6 month |
|---|---|
| 2026-06-30 | $30.00M 10-Q · filed 2026-08-13 |